miércoles, 25 de febrero de 2026

Will Novo Nordisk’s slashing of obesity drug prices save patients’ money? It depends Experts say some will benefit from cuts to list prices, but it’s net prices that often matter more

https://www.statnews.com/2026/02/24/novo-nordisk-weight-loss-drug-price-cut-examined/ By Elaine ChenFeb. 24, 2026 Elaine Chen, a national biotech reporter, is the co-author of The Readout, a newsletter about the business, science, and politics of biotech.

No hay comentarios: